Cargando…

The Dental Management of Patients at Risk of Medication-Related Osteonecrosis of the Jaw: New Paradigm of Primary Prevention

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition that can considerably affect the quality of life of patients. Furthermore, even if its epidemiology and pathogenesis h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Fede, Olga, Panzarella, Vera, Mauceri, Rodolfo, Fusco, Vittorio, Bedogni, Alberto, Lo Muzio, Lorenzo, SIPMO ONJ Board, Campisi, Giuseppina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6164200/ https://www.ncbi.nlm.nih.gov/pubmed/30306086 http://dx.doi.org/10.1155/2018/2684924

Ejemplares similares

The preventive care of medication-related osteonecrosis of the jaw (MRONJ): a position paper by Italian experts for dental hygienists
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

The Treatment of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review with a Pooled Analysis of Only Surgery versus Combined Protocols
por: Di Fede, Olga, et al.
Publicado: (2021)

Ozone Infiltration for Osteonecrosis of the Jaw Therapy: A Case Series
por: Di Fede, Olga, et al.
Publicado: (2022)

Conservative Surgical Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw with Er,Cr:YSGG Laser and Platelet-Rich Plasma: A Longitudinal Study
por: Mauceri, Rodolfo, et al.
Publicado: (2018)

Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020
por: Campisi, Giuseppina, et al.
Publicado: (2020)

Could the Combined Administration of Bone Antiresorptive Drug, Taxanes, and Corticosteroids Worsen Medication Related Osteonecrosis of the Jaws in Cancer Patients?
por: Oteri, Giacomo, et al.
Publicado: (2018)

One changing and challenging scenario: the treatment of cancer patients with bone metastases by bisphosphonates and denosumab, the cost–benefit evaluation of different options, and the risk of medication-related osteonecrosis of the jaw (MRONJ)
por: Fusco, Vittorio, et al.
Publicado: (2022)

Immune Dysfunction in Medication-Related Osteonecrosis of the Jaw
por: Roato, Ilaria, et al.
Publicado: (2023)

Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives
por: Cristaldi, Marta, et al.
Publicado: (2019)

Improving the cancer adult patient support network (iCAN): a pilot study on a communication model and modified focus group
por: Campisi, Giuseppina, et al.
Publicado: (2023)

A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis
por: Campisi, Giuseppina, et al.
Publicado: (2021)

Low Frequency of Human Papillomavirus in Strictly Site-Coded Oral Squamous Cell Carcinomas, Using the Latest NHI/SEER-ICD Systems: A Pilot Observational Study and Critical Review
por: Panzarella, Vera, et al.
Publicado: (2021)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
por: Fusco, Vittorio, et al.
Publicado: (2018)

Site-Coded Oral Squamous Cell Carcinoma Evaluation by Optical Coherence Tomography (OCT): A Descriptive Pilot Study
por: Panzarella, Vera, et al.
Publicado: (2022)

Salivary Microbiota Composition in Patients with Oral Squamous Cell Carcinoma: A Systematic Review
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)
por: Bedogni, A, et al.
Publicado: (2012)

Can radium 223 be a conservative non-surgical management of medication-related osteonecrosis of the jaw?
por: Costa, Renato Patrizio, et al.
Publicado: (2019)

Oral Health Status in Subjects with Amnestic Mild Cognitive Impairment and Alzheimer’s Disease: Data from the Zabút Aging Project
por: Panzarella, Vera, et al.
Publicado: (2022)

Diagnostic delay of oral squamous cell carcinoma and the fear of diagnosis: A scoping review
por: Mauceri, Rodolfo, et al.
Publicado: (2022)

Oral verruciform xanthoma and erythroplakia associated with chronic graft-versus-host disease: a rare case report and review of the literature
por: Capocasale, Giorgia, et al.
Publicado: (2017)

Current Controversies in Classification, Management, and Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw
por: Ascani, Giuliano, et al.
Publicado: (2014)

Doctoral: A smartphone-based decision support tool for the early detection of oral potentially malignant disorders
por: Di Fede, Olga, et al.
Publicado: (2023)

Bisphosphonate-related osteonecrosis of the jaw and dental implants
por: Qamheya, Ala Hassan A., et al.
Publicado: (2016)

Appropriateness in Dentistry: A Survey Discovers Improper Procedures in Oral Medicine and Surgery
por: Oteri, Giacomo, et al.
Publicado: (2018)

Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023)

Dental students' knowledge of medication-related osteonecrosis of the jaw
por: Rosella, Daniele, et al.
Publicado: (2017)

Immune-Mediated Desquamative Gingivitis and Optical Coherence Tomography Diagnostic Patterns: Clinical Implication from a Systematic Review
por: Panzarella, Vera, et al.
Publicado: (2021)

Peri‐implantitis‐like medication‐related osteonecrosis of the jaw: Clinical considerations and histological evaluation with confocal laser scanning microscope
por: Tempesta, Angela, et al.
Publicado: (2021)

The Management of Dental Practices in the Post-COVID 19 Era: An Economic and Operational Perspective
por: Lo Nigro, Giovanna, et al.
Publicado: (2020)

Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)

Osteonecrosis of the jaw and denosumab
por: Goss, Alastair N
Publicado: (2022)

Dental extraction following zoledronate, induces osteonecrosis in rat´s jaw
por: Vidal-Gutiérrez, Ximena, et al.
Publicado: (2017)

Mesenchymal stem cells in the treatment of osteonecrosis of the jaw
por: Nifosì, Gianfilippo, et al.
Publicado: (2021)

Dental practitioners' and students' knowledge of medication related osteonecrosis of the jaw (MRONJ)
por: Almousa, Mandlin Abdulaziz, et al.
Publicado: (2021)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
por: Lee, Emily Sunny, et al.
Publicado: (2023)

Bisphophonates related osteonecrosis of the jaw
por: Gupta, Swati, et al.
Publicado: (2013)

A rare case of bevacizumab-related osteonecrosis of the jaw associated with dental implants
por: Maluf, Gustavo, et al.
Publicado: (2019)

Medication-related osteonecrosis of the jaw after dental clearance: Prevalence in an oncology center
por: Hajeri, Saad, et al.
Publicado: (2022)

MRONJ in breast cancer patients under bone modifying agents for cancer treatment-induced bone loss (CTIBL): a multi-hospital-based case series
por: Mauceri, Rodolfo, et al.
Publicado: (2023)

Osteonecrosis of the jaw in the era of targeted therapy and immunotherapy in oncology
por: Nifosì, Antonio Fabrizio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pgjc903hm76jljm7g7dr6vsnt8